Preoperative Chemotherapy With Bevacizumab For Potentially Resectable Gastric Cancer With Liver Metastasis
Status:
Unknown status
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The investigators assessed whether the addition of a preoperative regimen of Bevacizumab
regimen to improves R0 resection rate and survival among patients with potentially resectable
gastric cancer with liver metastasis.